The Rise in Alzheimer’s Diagnosis
Advances in modern medicine have extended life expectancy by preventing heart attacks through exercise and medications for high blood pressure and cholesterol, as well as by improving early cancer detection with modern screenings and tests. These remarkable achievements mean that more people are now reaching ages where the risk of Alzheimer’s is higher. This rise in patients underscores the urgent need to develop effective prevention strategies and treatments.
Lifestyle Factors That Make a Difference
The Lancet medical journal published encouraging research showing that lifestyle choices can significantly reduce the risk of Alzheimer’s disease. Professor Weiser emphasizes three protective factors in particular: regular physical exercise, a healthy and balanced diet, and ongoing mental stimulation. These habits not only support overall health but also help protect the brain by keeping it active, resilient, and less vulnerable to decline. The findings are hopeful, as they highlight that people have more influence over their Alzheimer’s risk than previously believed, and that everyday choices can play a meaningful role in long-term brain health.
Progress in Alzheimer’s Treatment and the Importance of Early Detection
Newly approved medications represent a promising advance in the treatment of Alzheimer’s disease by targeting amyloid, a harmful protein that builds up in the brain. Professor Weiser describes these drugs as a major breakthrough. They not only reduce amyloid accumulation but also have the potential to slow the progression of the disease when introduced in its early stages. This makes early intervention crucial, as the treatments are most effective before significant cognitive decline has occurred.
Recognizing the Signs of Alzheimer’s
Professor Weiser explains how to distinguish between normal aging and the early signs of dementia. Normal aging may include occasionally forgetting names or experiencing minor memory lapses that do not interfere with daily life, and these changes usually remain stable over time.
Concerns arise, however, when memory problems worsen progressively, daily functioning becomes affected, and family members begin to notice significant changes. At this point, consulting a neurologist or psychiatrist is essential. An early diagnosis not only clarifies the situation but also opens the door to treatment options.
A Renewed Focus on Research and Development
New treatment approvals have energized Alzheimer’s research. While earlier drugs failed and were withdrawn, current successes provide valuable insights into disease mechanisms. This scientific momentum offers hope for current patients and future breakthrough treatments.
For deeper insights into prevention, early detection, and the latest treatments, watch the full “Doctor on Call” video with Professor Weiser.
More Posts
Home at Last: The Returning Hostages’ Journey Back to Life
On October 13, 2025, Israel witnessed a day that will never be forgotten. The last twenty living Israeli hostages were finally returned home after more than two years in captivity. Across the country, people sat in front of screens at home and at work, holding their breath as they waited to see their loved ones come home. It was a day filled with both fear and hope — fear of what the hostages had endured and of the long recovery ahead, and hope that, together, we will heal and rebuild.
Dr. Tiran Golani Represents Sheba Global Ophthalmology at ESCRS 2025 in Copenhagen
In September 2025, Dr. Tiran Golani, Ophthalmology Resident at the Goldschleger Eye Institute, attended the European Society of Cataract and Refractive Surgeons (ESCRS) Conference in Copenhagen. Representing Sheba Global Ophthalmology, she presented research conducted alongside Dr. Hostovsky and colleagues at Sheba Global Ophthalmology.
Advancing Autoimmune Care: Insights from Sheba’s CAR T-Cell Therapy Webinar
More than 300 healthcare professionals from 34 countries joined Sheba Medical Center’s webinar on CAR T-cell therapy, offered as part of a research program for autoimmune diseases. Led by Prof. Merav Lidar and Prof. Elad Jacoby, the session explored new clinical possibilities, shared emerging research, and fostered international dialogue on one of medicine’s cutting-edge treatment frontiers.
